DAVID SCHAFFER - 29 Sep 2021 Form 4 Insider Report for 4D Molecular Therapeutics Inc. (FDMT)

Role
Director
Signature
/s/ August J. Moretti, Attorney-in-Fact for David Schaffer
Issuer symbol
FDMT
Transactions as of
29 Sep 2021
Net transactions value
-$815,863
Form type
4
Filing time
01 Oct 2021, 16:34:19 UTC
Previous filing
29 Sep 2021
Next filing
22 Oct 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction FDMT Common Stock Sale $218,512 -7,806 -0.81% $27.99 958,950 29 Sep 2021 Direct F1, F2
transaction FDMT Common Stock Sale $243,058 -8,365 -0.87% $29.06 950,585 29 Sep 2021 Direct F1, F3
transaction FDMT Common Stock Sale $21,044 -700 -0.07% $30.06 949,885 29 Sep 2021 Direct F1, F4
transaction FDMT Common Stock Sale $209,165 -7,836 -0.82% $26.69 942,049 30 Sep 2021 Direct F1, F5
transaction FDMT Common Stock Sale $124,085 -4,549 -0.48% $27.28 937,500 30 Sep 2021 Direct F1, F6
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person.
F2 The transaction was executed in multiple trades in prices ranging from $27.70 to $28.70, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The reporting person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
F3 The transaction was executed in multiple trades in prices ranging from $28.71 to $29.69, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The reporting person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
F4 The transaction was executed in multiple trades in prices ranging from $29.75 to $30.66, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The reporting person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
F5 The transaction was executed in multiple trades in prices ranging from $26.07 to $27.06, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The reporting person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
F6 The transaction was executed in multiple trades in prices ranging from $27.08 to $27.83, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The reporting person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.